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ABSTRACT
Identifying a patient’s key problems over time is a common task
for providers at the point care, yet a complex and time-consuming
activity given current electric health records. To enable a problem-
oriented summarizer to identify a patient’s comprehensive list of
problems and their salience, we propose an unsupervised phe-
notyping approach that jointly learns a large number of pheno-
types/problems across structured and unstructured data. To iden-
tify the appropriate granularity of the learned phenotypes, the
model is trained on a target patient population of the same clinic.
To enable the content organization of a problem-oriented sum-
marizer, the model identifies phenotype relatedness as well. The
model leverages a correlated-mixed membership approach with
variational inference applied to heterogenous clinical data. In this
paper, we focus our experiments on assessing the learned phe-
notypes and their relatedness as learned from a specific patient
population. We ground our experiments in phenotyping patients
from an HIV clinic in a large urban care institution (n=7,523), where
patients have voluminous, longitudinal documentation, and where
providers would benefit from summaries of these patient’s medical
histories, whether about their HIV or any comorbidities. We find
that the learned phenotypes and their relatedness are clinically
valid when assessed qualitatively by clinical experts, and that the
model surpasses baseline in inferring phenotype-relatedness when
comparing to existing expert-curated condition groupings.
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Patient summarization, Graphical models, EHR, Phenotyping
1 INTRODUCTION
Electronic health records (EHR) have improved the availability of
patient records, but this has not always translated to increased
availability of relevant information to clinicians [5]. This is partly
because increased amounts of data in EHRs has made it more diffi-
cult for clinicians to review patients’ previous medical histories and
obtain an overview of the patient record [12]. Increased amounts
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patient data have also raised concerns regarding clinician infor-
mation overload [7], having effects on care quality[6], and patient
safety[18].
Patient record summarization has been suggested as a valuable
tool to support clinicians in making sense of increasingly large
patient records[8]. There are a number of open challenges associ-
ated with robust summarization of clinical documentation [16], in-
cluding content selection—identifying the right summary elements
at the right granularity in the input patient record— and content
organization—organizing summary output in a coherent and action-
able fashion for the clinicians, all the while preserving data prove-
nance. Previous work has shown that problem-oriented summary
supports the needs of clinicians [10, 14, 15, 20]. High-throughput
computational phenotyping methods are attractive for identifying
a patient’s problems in a robust and scalable fashion [11, 13, 17].
Considering the characteristics of electronic health record (EHR)
data (missingness, heterogeneity, uncertainty), Bayesian genera-
tive approaches are attractive to handle them and provide easily
interpretable outputs that quantify their uncertainty.
To enable a problem-oriented summarizer to identify a target
patient’s comprehensive list of problems and their salience, we
propose a probabilistic machine learning approach that can identify
a large number of phenotypes/problems using patients’ structured
and unstructured data in an unsupervised fashion. The machine
learning model is trained on the EHR data of many patients to
simultaneously learn probabilistic definitions of many phenotypes
at the same time. Figure 1 shows a graphical schema of the proposed
approach .
To identify the appropriate granularity of the learned pheno-
types, the model is trained on a target patient population of the
same clinic. Each phenotype definition is composed of diagnoses,
medications, laboratory tests, and clinical notes that have been
observed to commonly co-occur in the training patient popula-
tion. Figure 2 shows an example phenotype learned by the model.
Figure 3 shows phenotype-phenotype correlations learned by the
model. Phenotypes are labeled with their most probable diagnosis
code. The learned phenotypes from the model are then used to
summarize a single patient EHR data over time. Figure 4 shows
an automatically generated example summary of a single patient
record over a five year period that leverages the proposed approach.
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Figure 1: Example of five learned phenotypes and their
learned correlations
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Figure 2: Example of learned phenotype and its probabilis-
tic definition across the four data types (yellow for diagno-
sis codes, green for notes, purple for medications, and blue
for laboratory tests). The mostly likely diagnosis code is as-
signed as label for the phenotype.)
In this work we focus on phenotyping a population of patients
from an HIV clinic in a large urban care institution. HIV-positive
patient experience a high burden of disease, with many comorbidi-
ties due to the inflammatory nature of the virus and the toxicity of
their medications [9]. Moreover, due to high healthcare utilization,
patients have complex and long medical histories that are diffi-
cult to sift through, exacerbating the need for summarization. We
Depression
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Bipolar 
disorder 
phenotype
Dysthymic 
disorder
phenotype
Depression
Phenotype (2)
Attention deficit 
disorder phenotype
!=0.65!=0.7 !=0.68
!=0.75
Figure 3: Example of five learned phenotypes and their
learned correlations
Enter patient id:  Number of problems:  View past:  Label:  
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Figure 4: Example of patient-specific summary over five
years. The top five most salient problems in 2019 are visual-
ized andhow their documentation has evolved through time.
In this setup, the summary was produced at the year level
by binning the patient’s documentation for that time resolu-
tion. The patient has HIV-specific problems, although their
HIV is becoming asymptomatic, as well as comorbidities, all
cardiac in nature. (Relations among the inferred phenotypes
are not shown. Dates are changed to maintain patient pri-
vacy.)
hypothesize that 1) the model will learn many clinically valid phe-
notypes and phenotype relationships; 2) training the model on an
HIV-positive population will result in the identification of several
HIV phenotypes, representing the different presentations and pro-
gression stages of HIV—a granularity that would likely be missed
if trained on a more general and heterogeneous patient population;
3) the model will also learn non-HIV phenotypes, representative of
the many comorbidities of HIV; 4) the model will identify correla-
tions among phenotypes that indicate clinically valid relations of
different types beyond simple is-a relationships.
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2 METHODS
2.1 The model
The model we proposed is based on the correlated topic model
(CTM) [3]. In our context, topics are equivalent to phenotypes and
documents are the patient records. We make a methodological con-
tribution by expanding the CTM to support multiple input sources,
beyond the single input source usually assumed in topic modeling.
We make this important expansion to the model since unlike topic
identification in general text, clinical documentation is more than
just clinical notes. Instead, our model is able to learn phenotype def-
initions through identifying co-occuring patterns in clinical notes,
laboratory tests, ordered medications, and diagnosis codes. Incor-
porating multiple sources of data into the phenotypes definitions
allows for more robust phenotype definitions that can help over-
come the inaccuracies present in just relaying on an single source
of patient data. This is supported by previous work that has shown
that incorporating heterogenous data yields superior phenotypes
[17].
It has been previously proposed to leverage topic-model like
models to learn clinical phenotypes. Our model differs in that we
do not assume that phenotypes identified in each patient record
are independent from one another. We remove the assumption
of independence by allowing for phenotypes to be correlated. To
do this our model, like the original CTM, replaces the traditional
Dirichlet distribution used in Latent Dirchelet Allocation (LDA)
[4] to govern topic proportions with a logit-normal distribution[3].
The logit-normal distribution allows for phenotype proportions in
each patient record to be correlated with one another (through the
normal covariance matrix) but also sum up to 1 or 100% of the pa-
tient record, as desired when modeling proportions. Changing the
previously assumed Dirchelet distribution with a logit-normal dis-
tribution removes the conditional conjugacy between the posterior
distribution and prior distribution of the phenotype proportions.
To perform posterior inference Wang and Blei [19] propose Laplace
variational inference, a generalized form of variational inference
that can handle non-conjugate models. In this paper we generalize
the proposed Laplace Variational Inference even further to allow
for multiple input types. This makes the model inference especially
relevant to clinical data which contains many different data types.
The model training is time-agnostic and treats each patient record
as bag of observations, one for each data type. While motivation be-
hind the model is to assign phenotypes on a single patient level for
patient-level summarization, in this paper we focus on the learned
phenotypes on the population level. Each phenotype is labeled
using the most probably diagnosis code.
The generative process of each patient record (D) with Nm num-
ber of tokens for M data types is provided below. The graphical
representation of the model is presented in Figure 5.
(1) Draw log phenotype proportion νd ∼ N (µ0, Σ0)
(2) For each nm token (xd,nm ) in data type (m = 1, ...,M):
(a) Draw phenotype assignment zd,nm |νd ∼ Mult(π (νd ))
(b) Draw token xnm |znm , βk,m ∼ Mult(βznm )
µ0,⌃0 ⌫d zd,nm xd,nm  k,mNm
D
K
M
Figure 3: Multi-CTM
Figure 5: The graphical representation of the multi-input
correlated topic model. Multiple inputs are represented by
the additional plate notation M that is not present in the
single-input CTM model.
2.2 Probabilistic inference
The phenotype definitions and their correlations with one another
are obtained through performing Bayesian posterior inference
which estimates the conditional probability of the unobserved or
latent model variables given the observed model variables. In the
case of the proposed model this means calculating the probability
of the phenotype proportions of each patient record (ν ) and phe-
notype assignment of each input (Znm ) given the observed patient
data (Xnmd ) and phenotype distributions (β), or p(ν , z |xd,nm , β).
When the posterior distribution has a conjugate prior this greatly
simplifies the Bayesian analysis and allows for the use of popular
sampling methods for approximate inference such as Markov chain
Monte Carlo sampling such as Gibbs sampling as employed in [17].
However, conjugacy limits the types of distributions used in
the model, and thus restricts the flexibility of data modeling. In
order to allow for phenotypes to be correlated with one another
the prior distribution used to model the phenotype proportions
in the patient record needs to allow for phenotype correlations.
Since that is not possible with the Dirchelet distribution, it needs
to be replaced with a different distribution that meets this criteria.
However since the Dirichlet distribution is the conjugate prior to
the multivariate distribution used to model the phenotype data
assignments, this modeling change means that the model losses its
conditional conjugacy. Hence, deterministic approximate inference
methods such as variational inference is more feasible than other
sampling methods.
By contrast to sampling approximation methods for inference,
the theoretical guaranties of convergence of variational inference
methods to the true posterior have been less studied. However,
variational inference has become a popular inference method in
Bayesian statistics as it tends to be faster and scale better with large
and complex data [2]. Even in variational inference, some popular
implementations such asmean-field variational depend of conjugate
models. Wang and Blei [19] propose Laplace variational inference,
a generalized form of variational inference that can handle non-
conjugate models. The method uses Laplace approximations in
the coordinate ascent updates within the variational optimization
problem. This methods was shown to generalize to different types of
non-conjugate model and have superior performance compared to
the original ad-hoc inference method previously proposed here [3].
In this paper we generalized the Laplace Variational Inference for
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multiple input types. The mathematical derivation of the Laplace
variational inference with multiple input types is shown below.
2.3 Inference mathematical derivation
As presented in the graphical model (see Figure 5), the under-script
m represents them-th input type, wherem = 1, ...,M . The deriva-
tion below contributed to the previously proposed inference by
[19] by allowing for M input types instead of a single input type.
The model is represented by the joint probability distribution in
equation (1). The inference problem is to solve for the posterior dis-
tribution which is the conditional distribution of the latent variables
ν and z given x in equation (2).
p(ν , z,x) =
M∏
m=1
p(xm |zm )p(zm |ν )p(ν ) (1)
p(ν , z |x) = p(ν , z,x)∫
p(ν , z,x)dzdν (2)
The integral in the denominator of equation (2) is intractable to
compute exactly [3]. As proposed by [19] the posterior is approxi-
mated using Laplace Variational Inference through optimization. A
family of densities are posited over the latent variables. The model
assumptions include:
(1) The variational distribution is fully factorized:
q(ν , z) = q(ν )
M∏
m=1
q(zm ) (3)
(2) ν is real valued and p(ν ) is twice differentiable with respect
to ν
(3) The distribution p(zm |ν ) is in the exponential family:
p(zm |ν ) = h(zm )exp{η(ν )T t(zm ) − a(η(ν ))} (4)
(4) The distribution p(xm |zm ) is in the exponential exponential
family such that:
p(xm |zm ) = h(xm )exp{t(zm )T < t(xm ), 1 >} (5)
In variational inference the approximation for the posterior dis-
tribution is obtained through minimizing the Kullback-Leiber (KL)
divergence to the exact posterior.
q∗(ν , z) = arдminKL(Q(ν , z)| |P(ν , z |x) (6)
Under standard variational inference theory minimizing the KL
divergence between q(ν , z) and the true posterior p(ν , z |x) is the
same as maximizing the lower bound of the log marginal likelihood
of observed data x . Using Jensens’s inequality the variational object
L(q) is defined by equation (5).
loдp(x) = loд
∫
p(ν , z,x)dzdν
≥ Eq [loд(p(ν , z,x))] − Eq [loд(q(ν , z))]
= Eq [loд(p(ν , z,x))] − Eq [loд(q(ν )
M∏
m=1
q(zm )]
≡ L(q)
(7)
Setting the partial derivative of L(q) with respect to q to zero
provides the optimal variational updates to q(ν ) and q(zm ) seen
in Equations (9) and (10). When p(ν ) is conjugate to p(zm |ν ) then
equations (5) and (6) have closed form solutions. In the case of this
non-conjugate model [19] put forward approximates to the updates
using Laplace approximation.
q∗(ν ) ∝ exp{Eq(z)[loд
M∏
m=1
p(zm |ν )p(ν )]} (8)
q∗(z1) ∝ exp{Eq(ν )[loдp(x1 |z1)p(z1 |ν )]}
...
q∗(zm ) ∝ exp{Eq(ν )[loдp(xm |z1)p(zm |ν )]}
(9)
The following is the derivation of the variational update to q∗(ν )
using the previously stated assumption that p(zm |ν ) is assumed to
belong to the exponential family.
q∗(ν ) ∝ exp{Eq(z)[loд
M∏
m=1
p(zm |ν )p(ν )]}
= exp{Eq(z)[loдp(ν ) +
M∑
m=1
loд(zm |ν )]}
= exp{Eq(z)[
M∑
m=1
loд(h(zm )exp{η(ν )T t(zm ) − a(η(ν ))})) + loдp(ν )]}
= exp{Eq(z)[
M∑
m=1
(η(ν )T t(zm ) − a(η(ν ))) + loдp(ν )]}
= exp{Eq(z) f (ν )}
(10)
The function f (ν ) in Equation (10) has no closed form and this is
approximated with the following 2nd order Taylor approximation
around νˆ which is the ν that maximizes ∇f (ν ).
f (ν ) ≈ f (νˆ ) + ∇f (νˆ )(ν − νˆ ) + 12 (ν − νˆ )
T ∇2 f (νˆ )(ν − νˆ ) (11)
Thus the update for q(ν ) is approximate with N(νˆ ,−∇2 f (νˆ )−1)
The sufficient statistics of the exponential family are:
h(zm ) = 1
t(zm ) =
∑
n
zmn
η(ν ) = ν − loд{
∑
k
exp{ν }
a(η(ν )) = 0
(12)
Using the sufficient statistics above f (ν ) is the following:
f (ν ) =
M∑
m=1
(η(ν )T − a(η(ν )) − 12 (ν − µ0)
T Σ−10 (ν − µ0)
= η(ν )T
M∑
m=1
{Eq(z)[t(zm )]} −
1
2 (ν − µ0)
T Σ−10 (ν − µ0)
(13)
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The first derivative and second derivative of f (ν ) are the follow-
ing:
∇f (ν ) = πi (1[i=j] − πj )
M∑
m=1
Eq(z)[t(zm )] − Σ−10 (ν − µ0)
=
M∑
m=1
Eq(z)[t(zm ] − π
K∑
k=1
[
M∑
m=1
Eq(z)[t(zm )]]k − Σ−10 (ν − µ0)
(14)
where π ∝ exp{η(ν )}
∇2 f (ν )i j = (−πi1i=j + πiπj )
K∑
k=1
[
M∑
m=1
Eq(z)[t(z)]]k − (Σ−10 )i j (15)
The update to q(zm ) wherem = 1, ...,m is the following:
q∗(zm ) ∝ exp{Eq(ν )[loдp(xm |zm )p(zm |ν )]}
= exp{loдp(xm |zm ) + Eq(ν )[loдp(zm |ν )]}
(16)
Using the exponential form of p(zm |ν ) and p(xm |zm ):
loдq(zm ) = loдp(xm |zm ) + Eq(ν )[loдp(zm |ν )]
= loдp(xm |zm ) + loдh(zm ) + Eq(ν )[η(ν )T ]t(zm ) −C
= loдh(zm ) + t(zm )T < t(xm ), 1 > +loдh(zm )+
Eq(ν )[η(ν )T ]t(zm ) −C
(17)
q(zm ) ∝ h(zm )exp{Eq(ν )[η(ν )T ] + t(xm )T t(zm )} (18)
2.4 Dataset
The model was trained on the EHR data of 7,523 patients from an
HIV clinical from a large urban care institute. Patient data used
was fully identified for which the use was approved by the Institu-
tional Review Board of our institution. The data spanned 8 years
and included the data types: words from clinical notes, laboratory
tests ordered, medication orders, and assigned diagnoses codes
from across all clinical settings (inpatient, outpatient, emergency).
For the purpose of the model training each patient record was re-
stricted to the most recent 2.5 years data. The final training dataset
included the following total data counts and unique vocabulary size
in brackets: total words from clinical notes: 128,034,516 (unique:
25,894); total laboratory tests: 463,524 (unique: 129); total medica-
tions: 510,820 (unique: 6,714); and total diagnosis codes: 246,623
(unique: 2,956).
2.5 Model training and parameter selection
The parameters of the normal distribution governing phenotype
proportions νd were initialized with µ0 equal to a zero vector and
Σ0 set to the identity matrix. The phenotype distribution βk,m for
each input type was initialized with a Uniform distribution over the
(K-1) simplex. This equivalent to initializing topics with a Dirichlet
distribution with parametrization of 1. A small amount of random
positive noise was added to each uniform distribution so there was
a small variation in the initial phenotypes. Three alternatives of
the model were estimated (K=50, 100, 250).
To identify the best performing model of the three alternative
number of phenotype (K=50, 100, 250), a clinical expert reviewed
20 randomly selected phenotypes from each model. The best per-
forming model is further evaluated for the clinical correctness of
the phenotypes and phenotype-relatedness learned by the model.
3 EVALUATION SETUP
We evaluate our hypotheses 1 through 4 using a mixture of quali-
tative and quantitative evaluations. Qualitative evaluation of the
phenotypes and phenotype relatedness was performed by two clin-
ical experts. The quantitative evaluation was performed through
a comparison to the Clinical Classification Software (CCS), which
provides expert-curated manual classification of diagnosis codes
into largely clinically homogeneous groups [1]
3.1 Hypothesis 1: clinical validity
To evaluate the clinical validity of the learned phenotypes, 50 ran-
domly selected phenotypes were evaluated independently by two
clinicians. The phenotypes were evaluated according to their co-
herence, granularity, and label quality [17]. Previous works citing
clinical evaluation of phenotypes by experts have reported the
scoring of a single clinician [11, 17]. Since this scoring can very
subjective, we opted for two clinicians to score the phenotypes and
the final score assigned is the average of the two clinicians. Since
we did not want the opinion of one clinicians to be influenced by
the other, there was not adjudication stage in the scoring (common
on qualitative rating tasks made by more than one reviewer). This
made the qualitative evaluation a very stringent task. We provide
an analysis of the agreement between the clinicians scoring which
can illuminate the level of subjectivity of this type of evaluation.
Phenotype coherence. Phenotype coherence is meant to capture
the quality of each learned phenotype according to its most prob-
ably observations. A coherent phenotype is defined to describe a
single condition with few or no unrelated observations (clinical
words, labratory tests, medications, and diagnosis codes). The ex-
pert was asked to rate each phenotype as having: ‘bad coherence’
(score=1) , ‘some coherence’ (score=2), ‘good coherence’ (score=3),
or ‘excellent coherence’ (score=4). Phenotypes with ‘bad coherence’
should look like a random combination of observations, ‘some co-
herence’ indicates the observations assigned to the phenotype are
somewhat related to one another, ‘good coherence’ indicates the
phenotype is a very good representation of a disease, and ‘excel-
lent coherence’ indicates the phenotype definition has almost no
unrelated observations assigned to it.
Phenotype granularity. The clinical experts were asked to char-
acterize the granularity of each randomly selected phenotype by
assessing whether the model learned a ‘single disease’ (score=3), a
‘group of diseases’ (score=2), or a ’non-disease’ phenotype (score=1).
Label quality. The representativeness of the automatically as-
signed phenotype label of the phenotype as a whole was evaluated.
Each label was categorized by the clinical experts as ‘unrelated’ to
the rest of the phenotype (score=1), ‘related’ to the rest of the phe-
notype (score=2), or ‘actionable’ (score=3). Labels that were deemed
as actionable are those representative of a single phenotype and
have the appropriate granularity to provide a clinician information
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that could be used without additional information to guide further
testing, diagnosis, or counseling.
Phenotype relatedness. Next, the clinical validity of the phenotypes-
relatedness were evaluated by a single clinical expert. The expert
reviewed all phenotypes relationships that were indicated to have
a correlation greater than 0.5 correlation coefficient. Two sets of
phenotype-relationships evaluated: 1) positive phenotype relation-
ships learned between "more common" non-hiv phenotypes, defined
as phenotypes that were represented in more than 5% of the patient
population in our dataset; and 2) positive relationships learned
between "rarer" non-hiv phenotypes, represented in 5% of sample
population or less. The justification for evaluating relationships
between "more common" phenotypes is that the model findings are
grounded in more patient record, which could result in more robust
findings. However, evaluating phenotype relationships identified
between "rarer" phenotypes could still be interesting to assess in
case the model is able to identify less known clinical relationships.
3.2 Hypothesis 2: focus on HIV phenotypes
Our second hypothesis was that since HIV is a complex disorder
with diverse presentations and severity among patients, the model
would identify several distinct HIV phenotypes. In evaluating this
hypothesis, we wished to understand to what extent the model
is able to learn multiple clinically valid HIV phenotypes and also
characterize what those phenotypes were. To do so we had an HIV
clinical expert review all the phenotypes automatically labeled as
’HIV’. The clinical expert was asked to i) indicate if the phenotype
was clinically valid, ii) indicate if the phenotype was indeed an
’HIV’ phenotypes; and iii) give a more granular description of the
phenotype if it was indeed an ’HIV’ phenotype in order to assess if
the model identified disease progression, presentation, or acuity.
3.3 Hypothesis 3: focus on non-HIV
phenotypes
To assess if the model was able to learn diverse phenotypes, rep-
resentative of the many comorbidities of HIV we quantitatively
compared the phenotypes learned to the disease groups identified
in the CCS. We did this by categorizing all 250 learned phenotypes
according to their labels’ corresponding CCS level-1 category. If
the model was able to learn phenotypes that fit into many CCS
categories, we would could conclude that the model was able to
learn diverse types of phenotypes, beyond HIV.
3.4 Hypothesis 4: types of phenotype-
relatedness
Weperformed two evaluations to assess whether themodel was able
to identify correlations among phenotypes that indicate clinically
valid relations of different types beyond simple is-a relationships.
The first evaluation included a clinical expert review phenotypes
identified by the model as highly related and determine what kind
of relationship type the model learned. Example relationship types
include comorbidities, same phenotype, phenotype subtype, and
others. The second evaluation we counted how many significant
relations learned by the model indicated an is-a relationship, as
Table 1: Comparison of 2 clinician scoring for phenotype co-
herence
Clinician 1
Not Coherent Coherent
Clinician 2 Not Coherent 1 1
Coherent 4 45
evidenced by same level-1 CCS categories, versus a more diverse
relation type such as comorbidity when spanning different CCS
categories.
4 RESULTS
The qualitative evaluation by the clinical expert indicated that
the 250-phenotype model yielded the most coherent and granular
phenotypes of the three models (K=50, 100, 250). All results below
are described for the evaluation performed for the K=250 phenotype
model.
4.1 Hypothesis 1: clinical validity
Phenotype quality. Of the 50 evaluated phenotypes from the
250-phenotype model, 10% of the phenotypes (n=5) were deemed
to have no coherence (average coherence score of 1 or 1.5) while
the large majority of evaluated phenotypes (n=45) were deemed
to be coherent (with average coherence score of 2 or above) (see
Figure 6). The most number of phenotypes were scored as having
’good coherence’ (n=13), followed by 12 phenotypes with an average
of 3.5 (between ‘good coherence’ and ‘excellent coherence’). The
‘bad coherence’ phenotypes were found to be non-disease specific,
but instead captured documentation related to general primary care
visits. Figure 7 shows the diagnosis codes of example phenotypes
with coherence scores 1 (‘bad coherence’) through 4 (‘excellent
coherence’) by both the clinical experts. The phenotypes in the
example identified a clinic visit phenotype (scored 1), grouping of
cancers phentoype (scored 2), grouping of heart diseases phenotype
(scored 3), and an Aterial fibrillation phenotype (scored 4).
Comparing the coherence phenotype scoring assigned by the
two clinicians we found that the two clinicians had a low agreement
on the exact coherence score assigned to the phenotypes (scores 1
through 4) but that the average difference between the scores was
less than 1 point (0.9). This indicates that the clinicians evaluation
of the phenotypes was not far apart. When comparing the clinician
agreement on whether a phenotype was identified as not coherent
(score of 1) versus coherent (score of 2 and above) the agreement
was high, at 90% of the evaluated phenotypes (see Table 1). Of
the 5 phenotypes that the reviewers did not agree on, 4 looked
like HIV clinic well visits. The disagreement seemed to stem from
whether the model identified a disease phenotype or a clinical-
settings phenotype. An example such phenotype had the following
top 5 diagnosis codes: ‘Human immune virus disease’, ‘Obesity
NOS’, ‘Elevated blood pressure w/o hypertension’, ‘Hypertension
NOS’, and ‘Laboratory exam NOS’.
The phenotype granularity scores indicated that 90% of the eval-
uated phenotypes (n=47) had a granularity score 2 or greater (see
Figure 8). This means that almost all of the evaluated phenotypes
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Figure 6: Phenotype coherence scores. Average score across
the two clinical expert scores. Score 1=‘bad coherence’,
2=‘good coherence’, 3= ‘very good coherence’, 4=‘excellent
coherence’.
were deemed by both reviewers to identify a single or a group of
diseases. The most number of phenotypes were assigned an aver-
age score of 2.5 (n=31), the next most prevalent score was 2 (n=13).
This indicates that the model mostly identified phenotypes that
were a group of diseases rather than a single disease. An example
of a phenotype that had an average granularity score of 2.5 had
different diagnoses codes identifying a fall or accident and different
body parts such as shoulder, forearm, limb and hand. One reviewer
scored the phenotype as identifying a single disease being ‘limb
injury due to accident’, while the other reviewer believed that since
multiple body parts were identified the phenotype represented a
group of diseases.
The phenotype labels were mostly found to be ‘related’ with a
score of 2.5 (n=21) or 2 (n=19) (see Figure 9). Only 3 phenotype labels
were identified as ‘actionable’ with a score of 3 by both reviewers.
The feedback from the reviewers was that the diagnosis code used
for the phenotypes was too granular to adequately represent the
entire phenotype.
Phenotype-relatedness quality. Of the learned phenotype-pair
correlations, 471 (1.5% of all possible phenotype-phenotype pairs)
were significant (correlation coefficient above 0.5 in absolute value).
Of the 471 significantly correlated phenotype-pairs, 395 where
positive correlated (Figure 10) and 76 were negatively correlated.
We had a clinical expert perform clinical validity of the learned
phenotype relationships.
In the "more common" phenotype set, 82 phenotype pairs were
found to have a correlation greater than 0.5 (Figure 11). These 82
correlations resulted from 61 unique phenotypes, hence on average
each phenotype had more than significant correlation with more
than one phenotype. Of the 82 reviewed relations 80 (98%) were
found clinically valid. One relation rated non clinically valid was the
high correlation between a non-disease phenotype for outpatient
visits and a non-disease phenotype for inpatient visits. The other
non clinically valid relation was between a joint disease phenotype
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Figure 7: Example phenotypes by coherence score assigned
by the clinical experts. Each phenotype is represented here
by its top diagnosis codes rather than all 4 data types for the
sake of space. Score 1=‘bad coherence’, 2=‘good coherence’,
3= ‘very good coherence’, 4=‘excellent coherence’.
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Figure 8: Phenotype granularity scores. Average score
across the two clinical expert scores. Score 1=’non disease’,
2=’group of diseases’, 3= ’single disease’.
and a phenotype that seemed to be a mix of hepatitis C, liver disease,
and obesity.
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Figure 9: Phenotype coherence scores. Histogram of average
phenotype coherence scores assigned by the two clinical ex-
pert. Score 1=‘not related’, 2=‘related’, 3= ‘actionable’.
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Figure 10: All significant pairwise-positive correlations visu-
alized
In the "more rare" phenotype set, 21 phenotype pairs were found
be have a correlation greater than 0.5 (Figure 12). These 21 cor-
relations results from 23 unique phenotypes. Of the 21 reviewed
relations 12 (57%) were found to clinically valid. Most of phenotype
pairs that the clinician deemed as unrelated were not very coherent
phenotypes which could be expected from phenotypes that were
assigned to less of the 5% of the training set.
4.2 Hypothesis 2: focus on HIV phenotypes
Of the 250 phenotypes, 73 where identified as ’HIV’ according to
their automatically generated label. The clinical expert evaluation of
the these phenotypes showed that most of the identified phenotypes
represented a routine primary care visit of an HIV patient. Three
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Figure 11: Significant pairwise-positive correlations evalu-
ated by clinician for clinical correctness.
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Figure 12: All sig ificant pairwise-positive correlations for
‘rare’ phenotypes (defined as present in less than 5% of the
training set).
phenotypes were clear representations of HIV phenotype and two
other phenotypes representing AIDS, the development of HIV into
a disease. The rest of the phenotypes were of HIV comorbidities
(psychiatric, cancer, renal, neurological, etc) mixed with HIV related
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Table 2: 250 phenotypes by their CCS category
CCS level 1 Category Number of
Category phenotypes
Infectious and parasitic diseases 83
Mental illness 32
Circulatory system 26
Neoplasms 23
Respiratory sys. 13
Endocrine; nutritional; and metabolic diseases 12
Digestive sys. 10
Musculoskeletal system and connective tissue 10
Genitourinary system 10
Nervous system and sense organs 8
Symp; signs; and ill-defined conditions 8
Blood and blood-forming organs 6
Injury and poisoning 4
Skin and subcutaneous tissue 3
Complications of pregnancy 1
Resid. codes; unclassified; all E codes 1
Certain cond. originating in perinatal period 0
Congenital anomalies 0
observations. A few phenotypes captured behavioral phenotypes
(substance abuse) and 11 phenotypes were deemed as non-coherent.
4.3 Hypothesis 3: focus on non-HIV
phenotypes
When categorized into CCS categories according to their ICD label,
the learned phenotypes were were found to cover 16 out of the
18 CCS level 1 classifications (Table 2). The two CCS level 1 cate-
gories not captured in the phenotype labels pertained to pediatric
conditions. Beyond the most prevalent CCS category related to
HIV, ‘Mental Illness’ (which include substance use) and ‘Disease
of the circulatory system’ were the most frequent disease groups
identified by the model (Figure 13). This finding reflects the high
coverage of the learned phenotypes related to the types of condi-
tions characteristics of the input population.
4.4 Hypothesis 4: types of phenotype-
relatedness
Of the 82 relations evaluated, 63 fit into the same CCS multi-level
classification, level 1 category and thus could be inferred using the
CCS. However 19 relations were not of the same level 1 category.
Out of those 19, 2 were deemed to be unrelated by the clinical
expert, 17 relations (21%) were clinically correct and could not be
inferred from the CCS and showed more diversity in the relation
type learned: the phenotype for severe HIV and one representing
the non-disease ICU visits, as well as comorbidity relations like in
the pair for ‘end-stage renal disease’ and ‘acute respiratory failure.’
4.5 Patient-level summarization
After the model learns 250 phenotypes from the patient population
in the HIV clinic, the model can be applied to the data found in a
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Figure 13: 250 learned phenotypes colored by their labels’
corresponding CCS category. Size of the circle indicates pro-
portion of phenotype represented in the training set.
single patient record. Running the model inference on patient level
data (without re-learning the model parameters) provides a 250
dimensional summarization of the patient record. To summarize
the patient record over time, we can run the model inference on
the patient data after segmenting the patient data at the desired
time granularity. The identified phenotype proportions over time is
inputed to a sankey visualization presented in Figure 4. Each sankey
line represents a phenotype identified to be relevant in the patient
record. The hight of each sankey link indicates the proportion of
the phenotype in that period. In order to be actionable and avoid
information overload the summary showcases the patient’s top
5 problems. Top problems are defined at the phenotypes that are
found by the model to have the highest probability among the 250
phenotypes learned by the model. The visualization then illustrates
how the proportion of the phenotypes increased, decreased, or
stayed the same from one period to the next. As a clinical decision
support tool, this visualization of the change in phenotypes identi-
fied in the patient record could signal to users what health problems
the patient possess and how they have changed in salience over
time.
The described approach for patient summarizing using the pro-
posed phenotyping model benefits from several of the key charac-
teristics of the model. Since the phenotyping model is fully unsuper-
vised the model can easily be utilized for other patient populations
by re-training the model on relevant patient data. For instance if pa-
tient record summarization was desired for oncology patients, the
model can be retrained on oncology patients to learn cancer-specific
phenotypes as well relevant co-morbidity phenotypes. The patient
summary benefits from the high-throughput nature of the model in
that the model learns many phenotypes at the same time and is able
to summarize the patient record according to all the phenotypes
found to be prevalent in the patient record. Finally the model pro-
vides a probabilistic summary of the patient record. The generated
patient summary is probabilistic in two senses; 1) each data point
has a probability of being associated with the phenotypes; and 2)
the phenotype assignments to the patient is also probabilistic which
can be interpreted as the salience of the associated phenotype in
that time period.
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To ensure that the model provides a digestible summary of the
patient record we analyzed how many phenotypes are required
to capture a large majority of the patient record in our training
set. Since if we find that the model assigns a large number of phe-
notypes to each patient record then the proposed summary may
still provide too much information be useful at the bedside. In our
analysis we found that more than half of patients in our dataset
were almost completely described by 1-5 phenotypes (Figure 14).
The large majority of the remaining patients were described by
6-20 phenotypes. Hence, even though is trained to learn a large
number of phenotypes (K=250), each patient record is summarized
by only a few phenotypes. This indicates that the model has the
potential to reduce many thousands of data points in the record of
each patient to a list of a handful of problems and how they have
changed over time.
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Figure 14: Number of phenotypes needed to explain 90% of a
given patient record. For example, 65% of the patient records
in the training set are almost fully explained (90% of data)
by 1-5 phenotypes. Where each patient record may be ex-
plained by a different 1-5 phenotypes from the 250 pheno-
types the model learned from the entire patient cohort.
5 DISCUSSION
Evaluation results show the model simultaneously identifies 250
phenotypes with good coherence and coverage. Learned phenotype
relatedness were found clinically meaningful and diverse, identi-
fying some relations out of scope of the baseline resource. Our
experimentation shows that when training the model on a cohort
of HIV patients, the model learns multiple HIV phenotypes that can
provide good granularity when used for single-patient problem-
oriented summarization. The model was also found to identify a
wide range of non-HIV phenotypes, yet commonly encountered
in HIV patients. The learned phenotype-phenotype correlations
learned from the patient cohort could be used to group and organize
highly-related phenotypes in the patient-level summary, to provide
a clearer overview of the patient’s problems. In many settings but
notably urgent care and emergency settings in particular, patient
summarization enabled by this model, could provide clinicians a
tool for more rapid understanding of the patient comorbidities,
leading to better diagnosis, expedited referrals, and potentially a
reduction in over-testing. Our future work includes performing an
evaluation study of the patient record summarization in assisting
clinicians to review patient records more effectively and accurately.
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Code and phenotype correlations will be made available at publica-
tion time.
